Summary
PDB 2YEL deposited: 2011-03-25 modified: 2011-06-15
Title CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 WITH THE INHIBITOR GW841819X
Authors Bamborough, P., Blandel, F.M., Bouillot, A.M., Boullay, A.B., Boursier, E.V., Brusq, J.M., Chung, C.W., Clement, C.A., Coste, H., Delves, C., Flynn, H., Gellibert, F.J., Gosmini, R.L., Grimley, R.L., Homes, P., Hughes, S.A., Jones, E.J., Kirilovsky, J., Lee, K., Magny, S.M., Martin, S.L., Mirguet, O., Nicodeme, E., Prinjha, R.K., Riou, A.M., Toum, J., Uings, I.J., White, J.H., Wilde, J., Woodward, R.
Method X-RAY DIFFRACTION
Structure factors resolution 1.65 rfactor 0.16527 rfree 0.21119
DPI 0.28 theoretical min: 0.10
Related PDB Entries 2YDW 2YEK 2YEM
Citations

Epigenetic mechanisms of gene regulation have a profound role in normal development and disease processes. An integral part of this mechanism occurs through lysine acetylation of histone tails which are recognized by bromodomains. While the biological and structural characterization of many bromodomain containing proteins has advanced considerably, the therapeutic tractability of this protein family is only now becoming understood. This paper describes the discovery and molecular characterization of potent (nM) small molecule inhibitors that disrupt the function of the BET family of bromodomains (Brd2, Brd3, and Brd4). By using a combination of phenotypic screening, chemoproteomics, and biophysical studies, we have discovered that the protein-protein interactions between bromodomains and acetylated histones can be antagonized by selective small molecules that bind at the acetylated lysine recognition pocket. X-ray crystal structures of compounds bound into bromodomains of Brd2 and Brd4 elucidate the molecular interactions of binding and explain the precisely defined stereochemistry required for activity.

J.Med.Chem. 2011 Jun; 54(11):3827- doi:10.1021/JM200108T

Cross References
Database source Identifier Description
ChEMBL Document CHEMBL2150880
PubMed 21568322 JMCMAR
Biomolecule Structure Assembly Serial Assembly Type Conformational State Chains Ligands Atoms
2YEL/0 2YEL 0 monomer 0 1 2 1250